US42805E3062 - HSKA - A1H5J3 (XNCM)
HESKA CORP Acción
Sin cotización
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 24,39 % |
Perfil de la empresa para HESKA CORP Acción
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Fondos invertidos
Los siguientes fondos han invertido en: HESKA CORP invertido:
Fondo | Vol. en millones 84,80 | Porcentaje (%) 0,15 % |
Datos de la empresa para HESKA CORP Acción
Nombre HESKA CORP
Empresa Heska Corporation
Símbolo HSKA
Sitio web https://www.heska.com
Mercado principal
NASDAQ CAPITAL MARKET
WKN A1H5J3
ISIN US42805E3062
Tipo de valor Acción
Sector Healthcare
Industria Medical - Devices
CEO Mr. Kevin S. Wilson
Capitalización de mercado 1 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,8 T
Dirección 3760 Rocky Mountain Avenue, 80538 Loveland
Fecha de OPV 1997-07-01
Dividendos de 'HESKA CORP'
Fecha ex-dividendo | Dividendo por acción |
---|---|
26.09.2012 | 0,10 USD |
27.06.2012 | 0,10 USD |
28.03.2012 | 0,10 USD |
Splits de acciones
Fecha | Split |
---|---|
30.12.2010 | 1:10 |
Cambios de identificador
Fecha | De | A |
---|---|---|
31.01.2011 | HSKAD | HSKA |
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | HSKA |
Otras acciones
Los inversores que tienen HESKA CORP también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.